As reported by Coinotag, Portage Biotech, a biomedical technology company, has transitioned to a Toncoin (TON) treasury model in September 2025. The company generates revenue through staking to secure the TON network and invests in Telegram ecosystem projects, with a portion of the funds allocated to cancer research. AlphaTON CEO Brittany Kaiser highlighted the company's exploration of real-world asset tokenization (RWA) to decentralize scientific funding and remove traditional financial barriers. The model aims to accelerate biomedical innovation by leveraging blockchain technology and staking income.
Portage Biotech Pivots to Toncoin Treasury to Fund Cancer Research
CoinotagShare
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.